Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial

Macbeth, F., Noble, S., Evans, J. et al. (13 more authors) (2016) Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial. Journal of Clinical Oncology, 34 (5). pp. 488-494. ISSN 0732-183X

Abstract

Metadata

Authors/Creators:
  • Macbeth, F.
  • Noble, S.
  • Evans, J.
  • Ahmed, S.
  • Cohen, D.
  • Hood, K.
  • Knoyle, D.
  • Linnane, S.
  • Longo, M.
  • Moore, B.
  • Woll, P.J.
  • Appel, W.
  • Dickson, J.
  • Ferry, D.
  • Brammer, C.
  • Griffiths, G.
Copyright, Publisher and Additional Information: © 2015 American Society of Clinical Oncology. Reproduced in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 10 February 2016
  • Published (online): 23 December 2015
  • Accepted: 10 December 2015
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 24 May 2016 11:40
Last Modified: 02 Jul 2016 00:55
Published Version: http://dx.doi.org/10.1200/JCO.2015.64.0268
Status: Published
Publisher: American Society of Clinical Oncology
Refereed: Yes
Identification Number: https://doi.org/10.1200/JCO.2015.64.0268
Related URLs:

Share / Export

Statistics